Patients with low psoriasis body surface area (BSA) can have similar quality of life impacts and symptom burdens as those ...

The timing of immunotherapy initiation is not a significant factor in the outcomes of patients with extensive-stage small ...

The announcement of the new members of the CDC Advisory Committee on Immunization Practice comes days after the HHS secretary ...

Panelists discuss how current therapeutic strengths include 15 approved treatments with different mechanisms of action that ...

Panelists discuss how comorbidities such as scoliosis, dislocated hips, and nutritional issues affect spinal muscular atrophy ...

Adela Perolla, MD, PhD, is a hematologist at the University Hospital Center "Mother Teresa" in Tirana, Albania.

Panelists discuss how emerging intrathecal gene therapy for older patients with spinal muscular atrophy (SMA) shows modest ...

An artificial intelligence (AI)-driven machine learning model was refined and validated internationally to accurately classify acute leukemia subtypes from routine laboratory data, according to Merlin ...

This next-generation ROS1 tyrosine kinase inhibitor previously received breakthrough therapy and orphan drug designations for ...

Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

Both monotherapy and combination therapy containing epcoritamab had high response rates and survival benefits when compared ...

In contrast, when using the traditional race-adjusted creatinine-based equation (eGFRcr-ASR), the HR was 2.8 (95% CI, 1.6–4.9 ...